Category: Latest News
-
Explaining biotech: Bionxt Solutions (BNXT.C) advances MS product through animal study
Bionxt Solutions Inc. (BNXT.C) has finished a study on a new type of medicine strip that dissolves in your mouth. This strip is designed to treat multiple sclerosis (MS), a condition that affects the brain and nerves. The study looked at how well and how quickly the body absorbs the medicine from this strip compared…
-
Good Gamer Entertainment (GOOD.C) up 93% with switch to municipal AI software concept
In late 2021, the team behind market awareness/online marketing group Native Ads ventured into their own e-sports deal through the creation of Good Gamer Entertainment (GOOD.C). It, well, wasn’t a smash. To be fair, not many e-sports deals have been a smash. Most chased a sector everyone thought was going to be hot, but which struggled…
-
Ashley Gold (ASHL.C) does deal for pre-drilled US uranium asset right by future mill
When we last talked about Ashley Gold Corp (ASHL.C), we framed things as a one-man show diligently working his ass off to progress a gold property that had plenty of potential but was facing headwinds due to the general market malaise on gold. All he needed was a small amount of capital, we said, and…
-
Weed roll-up BZAM (BZAM.C) used stock to buy assets <60 days before asking for creditor protection
You’ve built a decent little company. You’ve grown some brands. You’re feeling okay about things when a bigger company comes along, offers you a bunch of their stock, making you a significant shareholder, and tells you there are other strong hands in the investor base, including the wealthy chairman who has been lending the company…
-
Lancaster Resources (LCR.C) adds a second run at green energy with uranium play
Traditionally, mid-to-large sized public companies stick to their knittting. A biotech company stays in biotech, a weed company stays in weed, a gold company shies away from oil and gas. But the beauty of being a microcap is you can be quick on your feet. Sure, you’ve got yourself a lithium project that checks all…
-
Lophos Pharma (MESC.C) now readies for natural and synthetic peyote production
Lophos Pharmaceuticals Corp. (MESC.C), a key player in the Canadian biosciences/psychedelics sector, has made a significant leap forward in the field of psychoactive compound research and development as it has announced the successful finalization of a new synthetic mescaline production protocol, marking a major milestone in the accessibility and study of psychoactive substances. This development…